Page last updated: 2024-11-07

aporphine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aporphine is a naturally occurring alkaloid found in various plants, notably in the family Lauraceae. It is a prototypical member of the aporphine class of alkaloids, which are known for their diverse pharmacological activities. Aporphine is a potent dopamine D2 receptor agonist, with potential applications in the treatment of Parkinson's disease. It has also shown promising effects in preclinical studies as an antidepressant, anxiolytic, and anti-inflammatory agent. Aporphine is synthesized via a complex biosynthetic pathway involving the condensation of tyrosine and dopamine. Its biosynthesis is regulated by several enzymes, including tyrosine hydroxylase, dopamine decarboxylase, and N-methyltransferase. Due to its pharmacological properties, aporphine has been the subject of extensive research. Studies have investigated its potential therapeutic applications, its mechanism of action, and its safety profile. The development of aporphine-based drugs is ongoing, and research is exploring its potential in treating various neurological and psychiatric disorders.'

aporphine: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

aporphine : An isoquinoline alkaloid that is the N-methyl derivative of 5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID114911
CHEBI ID35643
SCHEMBL ID59765
MeSH IDM0216825

Synonyms (18)

Synonym
CHEBI:35643
aporphine
478-57-9
6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline
unii-13ns2ktd6h
13ns2ktd6h ,
4h-dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-6-methyl-
6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo(de,g)quinoline
AM20040538
4h-dibenzo[de,g]quinoline,5,6,6a,7-tetrahydro-6-methyl-
SCHEMBL59765
BZKUYNBAFQJRDM-UHFFFAOYSA-N
aporphine, (+/-)-
5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo(de,g)quinoline
(+/-)-aporphine
6-methylnoraporphine
DTXSID80895017
Q4780565

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In an IN VIVO assay, administration of 1 resulted in 67% reduction of worm counts in mice at 25 mg/kg when dosed orally."( Anthelmintic activity of aporphine alkaloids from Cissampelos capensis.
Ayers, S; Brand, R; Brown, CM; Mohn, K; Murphy, T; Powell, JS; Pretorius, S; Singh, SB; Stevenson, D; Thompson, D; Zink, DL, 2007
)
0.64
" Greater energy doses and double sample's dosage also decreased microbial survival."( Antimicrobial photodynamic effect of extracts and oxoaporphine alkaloid isomoschatoline from Guatteria blepharophylla.
Alves Stefanello, MÉ; Andreazza, NL; Caramano de Lourenço, C; Hernandez-Tasco, ÁJ; Pinheiro, ML; Salvador, MJ; Vilaça Costa, E, 2016
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
isoquinoline alkaloid fundamental parent
aporphine alkaloidAny benzylisoquinoline alkaloid that has a structure based on 4H-dibenzo[de,g]quinoline or its 3-methyl derivative.
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (84)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (5.95)18.7374
1990's11 (13.10)18.2507
2000's19 (22.62)29.6817
2010's43 (51.19)24.3611
2020's6 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.48 (24.57)
Research Supply Index4.47 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index94.97 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (4.65%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other82 (95.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]